Evidence map›Paper›PMID 29761303›Full record

ArticleCancer causes & control : CCC2018

Racial differences in the relationship between tobacco, alcohol, and the risk of head and neck cancer: pooled analysis of US studies in the INHANCE Consortium.

Kristin J Voltzke, Yuan-Chin Amy Lee, Zuo-Feng Zhang, Jose P Zevallos, Guo-Pei Yu, Deborah M Winn, Thomas L Vaughan, Erich M Sturgis, Elaine Smith, Stephen M Schwartz and 12 more

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Laryngeal cancer incidence trends in the United States over 2000-2020: a population-based analysis.Archives of public health = Archives belges de sante publique · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Hazard of Cervical, Oropharyngeal, and Anal Cancers in HIV-Infected and HIV-Uninfected Medicaid Beneficiaries.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  16. Article
  17. Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden.Annals of oncology : official journal of the European Society for Medical Oncology · 2019
    Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 3 countries.

Kristin J VoltzkeDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA. kristin.voltzke@email.unc.edu.ORCID http://orcid.org/0000-0003-2179-6565
Yuan-Chin Amy LeeDivision of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Zuo-Feng ZhangUCLA School of Public Health, Los Angeles, CA, USA.
Jose P ZevallosDivision of Head and Neck Surgical Oncology in the Department of Otolaryngology/Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Guo-Pei YuMedical Informatics Center, Peking University, Beijing, China.
Deborah M WinnNational Cancer Institute, Bethesda, MD, USA.
Thomas L VaughanFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Erich M SturgisUT-M.D. Anderson Cancer Center, Houston, TX, USA.
Elaine SmithCollege of Public Health, University of Iowa, Iowa City, IA, USA.
Stephen M SchwartzFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Stimson SchantzNew York Eye and Ear Infirmary, New York, NY, USA.
Joshua MuscatPenn State College of Medicine, Hershey, PA, USA.
Hal MorgensternDepartments of Epidemiology and Environmental Health Sciences, School of Public Health and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
Michael McCleanBoston University School of Public Health, Boston, MA, USA.
Guojun LiUT-M.D. Anderson Cancer Center, Houston, TX, USA.
Philip LazarusWashington State University College of Pharmacy, Spokane, WA, USA.
Karl KelseyBrown University, Providence, RI, USA.
Maura GillisonJohns Hopkins Medical Institute, Baltimore, MD, USA.
Chu ChenFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Paolo BoffettaThe Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA.
Mia HashibeDivision of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Andrew F OlshanDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
Fred Hutch Cancer Center · USThe University of Texas MD Anderson Cancer Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Utah · USBoston University · USBrown University · USIcahn School of Medicine at Mount Sinai · USNational Cancer Institute · USNew York Eye and Ear Infirmary · USPeking University · CNPenn State Milton S. Hershey Medical Center · USUCLA Health · USUniversity of Iowa · USUniversity of Michigan · USWashington State University Spokane · USWashington University in St. Louis · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
UCLA SPORE IN LUNG CANCERP50CA090388 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2001 to 2008
$13.0M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
UDP GLUCURONOSYLTRANSFERASES, DETOXIFICATION OF NNKP01CA068384 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI LAZARUS, PHILIP · 1995 to 2005
$8.5M
UCLA CANCER EPIDEMIOLOGY TRAINING PROGRAMT32CA009142 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHANG, ZUO-FENG · 1986 to 2024
$6.3M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
The Boston Collaborative Oral Cancer StudyR01CA078609 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1999 to 2010
$5.3M
LUNG CANCER CHEMOPREVENTION WITH CELECOXIB IN EX-SMOKERSU01CA096134 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAO, JENNY T · 2002 to 2007
$5.1M
Gene Environment Interaction in Head and Neck CancerR01CA090731 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI OLSHAN, ANDREW · 2001 to 2005
$4.6M
UDPGLUCURONOSYLTRANSFERASE GENOTYPE AND ORAL CANCER RISKR01DE013158 · NIDCR · UNIVERSITY OF SOUTH FLORIDA · PI LAZARUS, PHILIP · 2000 to 2011
$3.6M
Patterns of Somatic Gene Alterations in Oral CancerR01CA100679 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 2004 to 2012
$2.6M
Oral HPV Infection in HIV-Infected Men and WomenR01DE016631 · NIDCR · OHIO STATE UNIVERSITY · PI GILLISON, MAURA L · 2005 to 2008
$2.5M
FIC NIH HHS R03 TW001500FIC NIH HHS TW001500National Institutes of Health (US) DE016631National Institutes of Health (US) R01CA100264National Institutes of Health (US) T32CA009142NCI NIH HHS Intramural Program of NCINCI NIH HHS K07 CA104231NCI NIH HHS P01 CA068384NCI NIH HHS P50 CA090388NCI NIH HHS R01 CA030022NCI NIH HHS R01 CA048996NCI NIH HHS R01 CA078609NCI NIH HHS R01 CA090731NCI NIH HHS R01 CA100264NCI NIH HHS R01 CA100679NCI NIH HHS R03 CA077954NCI NIH HHS R03 CA113157NCI NIH HHS R03CA113157NCI NIH HHS T32 CA009142NCI NIH HHS U01 CA096134NICHD NIH HHS P2C HD050924NIDA NIH HHS R01 DA011386NIDCR NIH HHS R01DE011979NIDCR NIH HHS R01 DE013110NIDCR NIH HHS R01DE013110NIDCR NIH HHS R01 DE013158NIDCR NIH HHS R01 DE016631NIDCR NIH HHS R03 DE016611NIDCR NIH HHS R03DE016611NIEHS NIH HHS P30 ES010126NIEHS NIH HHS P30ES010126NIEHS NIH HHS R01 ES011740NIEHS NIH HHS R21 ES011667NIH HHS K07CA104231NIH HHS P01CA068384NIH HHS P50CA090388NIH HHS R01CA030022NIH HHS R01CA048996NIH HHS R01CA051845NIH HHS R01CA061188NIH HHS R01CA078609NIH HHS R01CA100679NIH HHS R01DA011386NIH HHS R01DE012609NIH HHS R01DE013158NIH HHS R01ES011740NIH HHS R03CA077954NIH HHS R21ES011667NIH HHS U01CA096134
6 · The paper itself

Abstract

There have been few published studies on differences between Blacks and Whites in the estimated effects of alcohol and tobacco use on the incidence of head and neck cancer (HNC) in the United States. Previous studies have been limited by small numbers of Blacks. Using pooled data from 13 US case-control studies of oral, pharyngeal, and laryngeal cancers in the International Head and Neck Cancer Epidemiology Consortium, this study comprised a large number of Black HNC cases (n = 975). Logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) for several tobacco and alcohol consumption characteristics. Blacks were found to have consistently stronger associations than Whites for the majority of tobacco consumption variables. For example, compared to never smokers, Blacks who smoked cigarettes for > 30 years had an OR 4.53 (95% CI 3.22-6.39), which was larger than that observed in Whites (OR 3.01, 95% CI 2.73-3.33; p

Indexed as

Alcohol DrinkingCase-Control StudiesHead and Neck NeoplasmsHumansRacial GroupsRisk FactorsTobacco UseUnited StatesAfrican AmericanAlcoholCigarette smokingHead and neck cancerRacial differenceTobacco

Identifiers

PMID29761303
PMCPMC6626318
OpenAlexW2804649027

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.